Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 273

1.

[Comparative effects of policosanol and two HMG-CoA reductase inhibitors on type II hypercholesterolemia].

Prat H, Román O, Pino E.

Rev Med Chil. 1999 Mar;127(3):286-94. Spanish.

PMID:
10436712
[PubMed - indexed for MEDLINE]
2.

Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia.

Castaño G, Mas R, Fernández L, Illnait J, Mesa M, Alvarez E, Lezcay M.

Drugs Aging. 2003;20(2):153-63.

PMID:
12534315
[PubMed - indexed for MEDLINE]
3.

Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.

Castaño G, Mas R, Fernández L, Illnait J, Gámez R, Alvarez E.

Int J Clin Pharmacol Res. 2001;21(1):43-57.

PMID:
11708574
[PubMed - indexed for MEDLINE]
4.

Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.

Castaño G, Fernández L, Mas R, Illnait J, Gámez R, Mendoza S, Mesa M, Fernández J.

Drugs R D. 2005;6(4):207-19.

PMID:
16050054
[PubMed - indexed for MEDLINE]
5.

Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.

Crespo N, Illnait J, Más R, Fernández L, Fernández J, Castaño G.

Int J Clin Pharmacol Res. 1999;19(4):117-27.

PMID:
10939029
[PubMed - indexed for MEDLINE]
6.

Effects of policosanol on postmenopausal women with type II hypercholesterolemia.

Castaño G, Más R, Fernández L, Fernández JC, Illnait J, López LE, Alvarez E.

Gynecol Endocrinol. 2000 Jun;14(3):187-95.

PMID:
10923280
[PubMed - indexed for MEDLINE]
7.

Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.

Gentile S, Turco S, Guarino G, Sasso CF, Amodio M, Magliano P, Salvatore T, Corigliano G, Agrusta M, De Simone G, Gaeta I, Oliviero B, Torella R.

Diabetes Obes Metab. 2000 Dec;2(6):355-62.

PMID:
11225965
[PubMed - indexed for MEDLINE]
8.

Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.

Castaño G, Menéndez R, Más R, Amor A, Fernández JL, González RL, Lezcay M, Alvarez E.

Int J Clin Pharmacol Res. 2002;22(3-4):89-99.

PMID:
12837046
[PubMed - indexed for MEDLINE]
9.

Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial.

Cubeddu LX, Cubeddu RJ, Heimowitz T, Restrepo B, Lamas GA, Weinberg GB.

Am Heart J. 2006 Nov;152(5):982.e1-5.

PMID:
17070175
[PubMed - indexed for MEDLINE]
10.

Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.

Pappu AS, Bacon SP, Illingworth DR.

J Lab Clin Med. 2003 Apr;141(4):250-6.

PMID:
12677170
[PubMed - indexed for MEDLINE]
11.

Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial.

Dulin MF, Hatcher LF, Sasser HC, Barringer TA.

Am J Clin Nutr. 2006 Dec;84(6):1543-8.

PMID:
17158441
[PubMed - indexed for MEDLINE]
Free Article
12.

Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women.

Mirkin A, Mas R, Martinto M, Boccanera R, Robertis A, Poudes R, Fuster A, Lastreto E, Yañez M, Irico G, McCook B, Farré A.

Int J Clin Pharmacol Res. 2001;21(1):31-41.

PMID:
11708573
[PubMed - indexed for MEDLINE]
13.

Effects of policosanol and lovastatin in patients with intermittent claudication: a double-blind comparative pilot study.

Castaño G, Más R, Fernández L, Gámez R, Illnait J.

Angiology. 2003 Jan;54(1):25-38.

PMID:
12593493
[PubMed - indexed for MEDLINE]
14.

Treatment of hypercholesterolemia in NIDDM with policosanol.

Torres O, Agramonte AJ, Illnait J, Más Ferreiro R, Fernández L, Fernández JC.

Diabetes Care. 1995 Mar;18(3):393-7.

PMID:
7555484
[PubMed - indexed for MEDLINE]
15.

A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study.

Castaño G, Más R, Fernández L, Illnait J, Mendoza S, Gámez R, Fernández J, Mesa M.

Drugs Exp Clin Res. 2005;31 Suppl:31-44.

PMID:
16444910
[PubMed - indexed for MEDLINE]
16.

A comparative study of policosanol Versus acipimox in patients with type II hypercholesterolemia.

Alcocer L, Fernández L, Campos E, Más R.

Int J Tissue React. 1999;21(3):85-92.

PMID:
10645516
[PubMed - indexed for MEDLINE]
17.

A multiple-dose pharmacodynamic, safety, and pharmacokinetic comparison of extended- and immediate-release formulations of lovastatin.

Davidson MH, Lukacsko P, Sun JX, Phillips G, Walters E, Sterman A, Niecestro R, Friedhoff L.

Clin Ther. 2002 Jan;24(1):112-25.

PMID:
11833826
[PubMed - indexed for MEDLINE]
18.

Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia.

Steinmetz A, Schwartz T, Hehnke U, Kaffarnik H.

J Cardiovasc Pharmacol. 1996 Apr;27(4):563-70.

PMID:
8847874
[PubMed - indexed for MEDLINE]
19.

Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.

Castaño G, Más R, Arruzazabala ML, Noa M, Illnait J, Fernández JC, Molina V, Menéndez A.

Int J Clin Pharmacol Res. 1999;19(4):105-16.

PMID:
10939028
[PubMed - indexed for MEDLINE]
20.

Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects.

Greyling A, De Witt C, Oosthuizen W, Jerling JC.

Br J Nutr. 2006 May;95(5):968-75.

PMID:
16611388
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk